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Editorial on the Research Topic
mHealth: Self-Management and Complementary Psychiatric Treatment
The need to disseminate medical and psychological interventions using technology has been a
pressing issue for psychiatric populations who are significantly underserved by traditional health
services. As a case in point, only 44.8% of adults with mental illness in the United States have
received treatment in 2019 (1). mHealth refers to services and devices, such as online programmes,
mobile applications, virtual reality (VR) systems and videogames, that can be used to identify and
support those with mental health needs beyond the traditional one-to-one conversations in a clinic
with a doctor or therapist (2–4).
The purpose of this special issue was to capture recent advances in the way technology—under
the umbrella of mHealth—can be used to understand andmonitor the manifestation and trajectory
of emotional and psychiatric problems. The included papers illustrate how mHealth can be used
to support treatment and care, from fully automated self-management and monitoring systems
to blended interventions in which technology-enabled self-care is supported by a clinician, or
clinician-led care is supplemented by technology.
Three articles in this collection relate to schizophrenia and psychotic disorders. The first paper
by Buck et al. suggests that frequent measurements delivered by mobile technologies could be
leveraged to detect increases in psychotic symptoms that may precede relapses. Gowarty et al.
found that two smoking cessation mobile apps were usable and appealing among young adult
smokers with psychotic disorders; however, coaching at the start of treatment and app notifications
throughout treatment were important to promote uptake and engagement. Finally, Hänsel et al.
identified less color, lower saturation, and fewer faces in uploaded images on Instagram by
individuals with schizophrenia compared to healthy volunteers, suggesting that image-sharing
social media platforms can be an intriguing medium for prediction, identification, and monitoring
of serious mental illness.
Two studies were conducted at the interface of physical and mental health. First, Duthely et al.
designed a mobile two-way texting system that sends and receives simple messages to promote
adherence to anti-retroviral medications and medical appointments for ethnic minority women
living with HIV/AIDS. The authors concluded that depression was a significant predictor of viral
non-suppression and that mHealth has the potential to supplement medical care in this population,
once patient concerns about privacy and confidentiality are addressed. The second study by Janney
et al. identified patient preferences for three different wearables to promote physical activity in
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bipolar disorder. The armband (worn around the upper arm)
was the favorite, followed by the pedometer (worn around the
hip), and the actigraph (worn around the waist). Interestingly,
the order of preference was the reverse to the order of accuracy of
activity monitoring and reported problems (e.g., skin irritation),
and may have been influenced by factors such as being able
to wear the device discreetly or conceal it under clothes. Both
studies flagged patient preferences that could influence uptake
and usage of mHealth devices.
Virtual reality featured in two papers that discussed
mechanisms of reducing stress and fear. The first paper by
Lindner et al. used a VR system to enable graded, controlled
and repeated exposure to phobic stimuli associated with spiders.
Through longitudinal modeling that indirectly compared two
studies, one with instructions for real-life exposure virtual reality
post-therapy and one without such instructions, the paper
suggests that virtual exposure paired with real-life exposure can
maximize fear reduction as part of therapy. The second paper by
Kim et al. used VR natural scenes with a soothing soundtrack to
induce relaxation in individuals with high stress, as an alternative
to traditional biofeedback. The two relaxation methods showed
no differences in total perceived stress, but differential effects
on physiological outcomes suggested that VR may be more
effective for relaxation by means of parasympathetic activity and
traditional biofeedback by reducing muscle tension.
Finally, a brief report by Grunebaum et al. is the first to
show evidence of increased assay sensitivity of computerized
adaptive testing over traditional measures in a clinical trial
with participants who experienced suicidal depression. The
importance of this work is in showing that brief phone or
computer-based long-term follow-up assessments can be a
reliable method in detecting suicide risk and has the added value
of minimizing repeated measurement bias that can occur with
traditional fixed-length assessments.
This collection of eight articles exemplifies the diverse
ways in which mHealth can be applied across mental health
conditions and vulnerable populations, including suicidal
depression, generalized anxiety, specific phobia, HIV/AIDS,
bipolar disorder, schizophrenia, and psychotic disorders. With
reference to wearable technologies, a computerized adaptive
test, a mobile assessment system, two VR systems, a text
messaging service, Instagram and mobile apps, these eight
articles demonstrate how mHealth can support physical activity,
smoking cessation, psychiatric treatment adherence, detection of
onset or relapse of mental illness, symptom severity monitoring,
stress management, and psychological therapy.
One caveat that permeates all papers in this special issue
is that mHealth remains largely experimental and confined
within research settings, rather than being deployed in the
real world and in routine clinical settings. Digital media
can overcome geographical barriers and make the most
of the available workforce through remote consultations,
task-shifting and self-management; however, large-scale
implementation of digital psychiatry is slow and limited (5).
A silver lining of the COVID-19 pandemic is the growing
use and acceptability of technology as means to delivering
psychiatric care, which can be a steppingstone to scale up the
provision of care post-pandemic to those who need it the most
(6, 7).
Most mHealth evidence to-date relates to brief self-help
interventions for anxiety disorders and depression of mild-to-
moderate severity in the general population (8). The contribution
of the collection of articles in this special issue is, first,
in demonstrating mHealth’s potential to assess and support
people with a range of severe psychiatric conditions, such as
schizophrenia, bipolar disorder and suicidal depression, and
second, in using mHealth in creative and diverse ways, from
reducing vulnerability to stress before clinical symptoms develop,
to preventing relapse for those who have a clinical diagnosis and
receive psychiatric treatment.
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